TGA cracks down on unapproved peptides

“As the availability of unapproved peptide products has increased, so too has evidence of potential risk to consumers,” the head of the medicines regulator says The Therapeutic Goods Administration (TGA) has added peptides to its priority watch list amid rampant social media advertising and the illegal importation of the protein building blocks. Professor Anthony Lawler,